GILD Stock Chart & Stats
C$26.27
-C$1.04(-3.81%)
―
--
Day’s Range― - ―
52-Week RangeC$23.97 - C$31.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)905.00
Market Cap
C$237.30B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)2.7
Beta0.55
Next Earnings
Jul 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.21
Shares Outstanding1,240,679,600
10 Day Avg. Volume905
30 Day Avg. Volume905
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S News
GILD FAQ
What was Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S’s price range in the past 12 months?
Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S lowest stock price was C$23.97 and its highest was C$31.80 in the past 12 months.
What is Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S’s market cap?
Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S’s market cap is C$237.30B.
When is Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S’s upcoming earnings report date?
Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S’s upcoming earnings report date is Jul 30, 2026 which is in 19 days.
How were Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S’s earnings last quarter?
Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S released its earnings results on May 07, 2026. The company reported C$2.211 earnings per share for the quarter, beating the consensus estimate of N/A by C$2.211.
Is Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S overvalued?
According to Wall Street analysts Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S’s price is currently Undervalued.
Does Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S pay dividends?
Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S does not currently pay dividends.
What is Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S’s EPS estimate?
Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S have?
Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S has 1,240,679,600 shares outstanding.
What happened to Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S’s price movement after its last earnings report?
Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S reported an EPS of C$2.211 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.983%.
Which hedge fund is a major shareholder of Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S?
Currently, no hedge funds are holding shares in TSE:GILD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
42.17%
Trailing 12-Months
Asset Growth
-3.30%
Trailing 12-Months
Gilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S (GILD) Earnings & Revenues
Novartis AG CAD Hedged CIBC CDR
―
Sanofi SA Unsponsored CDR Hedged Reg S
―
Pfizer Inc. Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S
―
Merck & Co., Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S
―
Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S
―